Atlas Trials

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Clinical trial NCT02646319 · COMPLETED

Trial details

NCT number
NCT02646319
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Advanced Malignant NeoplasmCervical Squamous Cell CarcinomaEndometrial CarcinomaMalignant Uterine NeoplasmRecurrent Bladder CarcinomaRecurrent Breast CarcinomaRecurrent Cervical CarcinomaRecurrent Head and Neck CarcinomaRecurrent Malignant NeoplasmRecurrent Ovarian CarcinomaRecurrent Prostate CarcinomaRecurrent Renal Cell Carcinoma
Start date
2016-01-01
Primary completion
2017-09-05
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.